Background Systemic sclerosis (SSc) is a multi-organ autoimmune connective tissue
disease that causes endothelial injury, fibrosis, and autoimmunity. Interstitial lung disease …

Background: Interstitial lung disease (ILD) is an early complication affecting 47-84% of
scleroderma (SSc) patients and is the leading cause of death. Identifying factors that predict …

Objective: Investigate the clinical characteristics, treatment effects, and prognostic factors for
interstitial lung disease (ILD) in patients with systemic sclerosis (SSc). Methods: This …

Systemic sclerosis (SSc) is a connective tissue disorder with multiple organ involvement.
Interstitial lung disease (ILD) is particularly significant as it is the leading cause of death in …

Objective: To assess the morbidity, mortality and prognostic factors of patients with Systemic
Sclerosis (SSc) and Interstitial Lung Disease (ILD). Methods: A retrospective analysis of …

BACKGROUND Interstitial lung disease (ILD) is the leading cause of morbidity and mortality
in patients with systemic sclerosis (SSc); however, prognostication of SSc-associated ILD …

Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is usually detected in a
patient known to have SSc but may be diagnosed prior to SSc. We probed an insurance …

Background: Interstitial lung disease (ILD) stands as the primary cause of mortality in
patients with Systemic Sclerosis (SSc). Despite the identification of several risk factors to …

Background: Systemic sclerosis (SSc) is a systemic autoimmune disease characterized by
microangiopathy, inflammation, fibrosis. Interstitial lung disease (ILD) is common among …

Background Systemic sclerosis (SSc) is a heterogeneous autoimmune disease
characterized by the dysregulation of fibroblast function, causing multi-organ damage, which …